These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22632477

  • 1. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J, Gaudlitz K, Zschucke E, Yassouridis A, Pyrkosch L, Wittmann A, Holsboer F, Ströhle A.
    Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
    [Abstract] [Full Text] [Related]

  • 2. Increased response to a putative panicogenic nocebo administration in female patients with panic disorder.
    Ströhle A.
    J Psychiatr Res; 2000; 34(6):439-42. PubMed ID: 11165311
    [Abstract] [Full Text] [Related]

  • 3. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 4. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A, Kellner M, Holsboer F, Wiedemann K.
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 7. The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.
    Le Mellédo JM, Bradwejn J, Koszycki D, Bichet DG, Bellavance F.
    Biol Psychiatry; 1998 Sep 01; 44(5):364-6. PubMed ID: 9755359
    [Abstract] [Full Text] [Related]

  • 8. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J, Koszycki D, Shriqui C.
    Arch Gen Psychiatry; 1991 Jul 01; 48(7):603-10. PubMed ID: 2069490
    [Abstract] [Full Text] [Related]

  • 9. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D, Cox BJ, Bradwejn J.
    Am J Psychiatry; 1993 Dec 01; 150(12):1881-3. PubMed ID: 8238648
    [Abstract] [Full Text] [Related]

  • 10. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan 01; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of aging on cholecystokinin-induced panic.
    Flint AJ, Koszycki D, Vaccarino FJ, Cadieux A, Boulenger JP, Bradwejn J.
    Am J Psychiatry; 1998 Feb 01; 155(2):283-5. PubMed ID: 9464213
    [Abstract] [Full Text] [Related]

  • 15. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 01; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 16. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
    Bradwejn J, Koszycki D.
    Am J Psychiatry; 1994 Feb 01; 151(2):261-3. PubMed ID: 8296900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Feb 01; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 19. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E, Tõru I, Vasar V, Shlik J.
    J Psychopharmacol; 2004 Jun 01; 18(2):194-9. PubMed ID: 15260907
    [Abstract] [Full Text] [Related]

  • 20. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K.
    J Psychiatr Res; 2010 Dec 01; 44(16):1148-53. PubMed ID: 20451215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.